Lars A. Carlson
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Biochemistry top 0.2%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 71
-
- Lipid metabolism and disorders 29
- Cardiovascular Function and Risk Factors 18
- Co-authors
- Lars OröSune BergströmG. RosenhamerAnders HamstenLars Erik BöttigerLeif HolmquistMartin EricssonJonas Boberg
- Journals
- Atherosclerosis (25 papers)European Journal of Clinical Investigation (20 papers)Scandinavian Journal of Clinical and Laboratory Investigation (15 papers)Clinica Chimica Acta (11 papers)Life Sciences (8 papers)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Lars A. Carlson
292 papers receiving 13.3k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Endocrinology, Diabetes and Metabolism 5.1k
- Biochemistry 990
- Cardiology and Cardiovascular Medicine 2.8k
- Cancer Research 1.6k
- Physiology 2.7k
Countries citing papers authored by Lars A. Carlson
This map shows the geographic impact of Lars A. Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars A. Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars A. Carlson more than expected).
Fields of papers citing papers by Lars A. Carlson
This network shows the impact of papers produced by Lars A. Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars A. Carlson. The network helps show where Lars A. Carlson may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars A. Carlson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 16 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 42 | |
| 8 | 2020 | 11 | |
| 9 | 2018 | 126 | |
| 10 | 2018 | 1 | |
| 11 | 2012 | 75 | |
| 12 | 2010 | 121 | |
| 13 | 2001 | 45 | |
| 14 | 1993 | 210 | |
| 15 | 1989 | 18 | |
| 16 | 1988 | 48 | |
| 17 | Metabolic risk factors in ischemic cardiovascular disease | 1982 | 105 |
| 18 | Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. | 1979 | 223 |
| 19 | 1978 | 14 | |
| 20 | 1974 | 11 |
About Lars A. Carlson
Lars A. Carlson is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Biochemistry, Cancer Research and Physiology, having authored 296 papers that have together received 15.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (71 papers), Lipoproteins and Cardiovascular Health (61 papers), Cancer, Lipids, and Metabolism (31 papers), Adipose Tissue and Metabolism (29 papers), Lipid metabolism and disorders (29 papers), Muscle metabolism and nutrition (20 papers), Cardiovascular Function and Risk Factors (18 papers) and Pharmacology and Obesity Treatment (17 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.1k citations), Biochemistry (990 citations), Cardiology and Cardiovascular Medicine (2.8k citations), Cancer Research (1.6k citations) and Physiology (2.7k citations). Lars A. Carlson has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Lars Orö, Sune Bergström, G. Rosenhamer, Anders Hamsten, Lars Erik Böttiger, Leif Holmquist, Martin Ericsson, Jonas Boberg, Lars‐Göran Ekelund and James R. Weeks. Their work appears in journals such as Atherosclerosis, European Journal of Clinical Investigation, Scandinavian Journal of Clinical and Laboratory Investigation, Clinica Chimica Acta and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.